Merck & Co., Inc. is 208.5x more valuable than ARDELYX, INC. by market capitalization ($298.26 B vs $1.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARDX | MRK |
|---|---|---|
| Market cap | $1.43 B | $298.26 B |
| US-listed rank | #2382 | #45 |
| Revenue (latest FY) | $407.32M | $65.01B |
| Net income (latest FY) | -$62.00M | $18.25B |
| Net margin | -15.2% | 28.1% |
| P/E (trailing FY) | - | 16.3 |
| SEC filings | 1,143 | 996 |
Merck & Co., Inc. is 208.5x more valuable than ARDELYX, INC. by market capitalization ($298.26 B vs $1.43 B).
In their latest fiscal years, ARDELYX, INC. reported $407.32M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ARDELYX, INC. and Merck & Co., Inc., or browse the full rankings.